Link Pharma Chem Limited has formally notified BSE Limited that it is exempt from compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding disclosure of Related Party Transactions for the half year ended September 30, 2026.
The exemption is based on Regulation 15(2) of SEBI (LODR) Regulations, 2015, which states that companies with paid-up equity share capital not exceeding ₹10 crore and net worth not exceeding ₹25 crore as of the last day of the previous financial year are exempt from various corporate governance provisions.
Specifically, the company is exempt from compliance with regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 27 and clauses (b) to (i) and (t) of sub-regulation (2) of regulation 46 and para-C, D and E of Schedule V.
The company references BSE notice No. 20220425-30 dated April 25, 2022 as additional basis for this exemption from disclosure requirements.
The communication is digitally signed by Rishikesh Thakur, Managing Director (DIN: 08777265), and addressed to the Department of Corporate Services at BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001.
Financial Impact
No financial impact disclosed. The disclosure represents a regulatory compliance status update rather than a financial transaction or operational event.